[Management of pregnancy complicated by intrauterine fetal growth restriction]

Mariola Ropacka-Lesiak1, Grzegorz Breborowicz

  • 1Klinika Peinatologii I Ginekologii, Uniwersytet Medyczny, Poznań, Polska. mariolaropacka@poczta.onet.pl

Ginekologia Polska
|June 20, 2012
PubMed

Insights

This study outlines fetal surveillance for intrauterine growth restriction (IUGR) pregnancies using Fetal Medicine Foundation (FMF) guidelines. It details monitoring methods to prolong pregnancy, reduce prematurity risks, and prevent fetal demise.

Area of Science:

  • Perinatology
  • Fetal Medicine
  • Obstetrics

Background:

  • Intrauterine growth restriction (IUGR) signifies fetal growth below genetic potential.
  • Managing IUGR pregnancies requires precise fetal surveillance to optimize outcomes.

Purpose of the Study:

  • To present Fetal Medicine Foundation (FMF) guidelines for fetal surveillance in IUGR pregnancies.
  • To detail integrated monitoring strategies for managing IUGR and preventing adverse events.

Main Methods:

  • Integrated fetal monitoring incorporating Doppler velocimetry, fetal heart rate, biophysical profile, and amniotic fluid assessment.
  • Adherence to Fetal Medicine Foundation (FMF) protocols for surveillance and delivery timing.

Main Results:

  • Integrated monitoring aims to prolong gestation, mitigating prematurity complications.
  • Identification of symptoms preceding intrauterine demise is crucial for timely intervention.

Conclusions:

  • Fetal surveillance based on FMF guidelines is essential for managing IUGR.
  • Optimizing delivery timing according to FMF recommendations can prevent fetal loss and reduce prematurity.

Related Concept Videos

Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...